129 related articles for article (PubMed ID: 6683753)
1. Periosteal changes secondary to prostaglandin administration.
Ringel RE; Haney PJ; Brenner JI; Mancuso TJ; Roberts GS; Moulton AL; Berman MA
J Pediatr; 1983 Aug; 103(2):251-3. PubMed ID: 6683753
[No Abstract] [Full Text] [Related]
2. Prostaglandin-induced neonatal periostitis.
Letts M; Pang E; Simons J
J Pediatr Orthop; 1994; 14(6):809-13. PubMed ID: 7814600
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin-induced periostitis: a complication of long-term PGE1 infusion in an infant with congenital heart disease.
Ringel RE; Brenner JI; Haney PJ; Burns JE; Moulton AL; Berman MA
Radiology; 1982 Mar; 142(3):657-8. PubMed ID: 7199748
[No Abstract] [Full Text] [Related]
4. Prostaglandin-induced hyperostosis. A case report.
Drvaric DM; Parks WJ; Wyly JB; Dooley KJ; Plauth WH; Schmitt EW
Clin Orthop Relat Res; 1989 Sep; (246):300-4. PubMed ID: 2766619
[TBL] [Abstract][Full Text] [Related]
5. Bone changes from prostaglandin therapy.
Poznanski AK; Fernbach SK; Berry TE
Skeletal Radiol; 1985; 14(1):20-5. PubMed ID: 4023730
[TBL] [Abstract][Full Text] [Related]
6. [Prostaglandin-induced periostitis].
Nakagawa T; Hamada S; Nishiki T; Yamamoto I; Tachi K; Takahashi H
Rinsho Hoshasen; 1983 Jun; 28(6):715-8. PubMed ID: 6684701
[No Abstract] [Full Text] [Related]
7. Administration of E-type prostaglandins in ductus-dependent congenital heart disease.
Silove ED
Pediatr Cardiol; 1982; 2(4):303-5. PubMed ID: 6956847
[No Abstract] [Full Text] [Related]
8. Morphologic features of the ductus arteriosus after prostaglandin E1 administration for ductus-dependent congenital heart defects.
Park IS; Nihill MR; Titus JL
J Am Coll Cardiol; 1983 Feb; 1(2 Pt 1):471-5. PubMed ID: 6681824
[No Abstract] [Full Text] [Related]
9. Case report 701: Prostaglandin E1 (PGE1) periostitis.
Rowley RF; Lawson JP
Skeletal Radiol; 1991; 20(8):617-9. PubMed ID: 1776031
[TBL] [Abstract][Full Text] [Related]
10. The ductus arteriosus: why and how to manipulate its patency.
Drummond WH; Bucciarelli RL; Gessner IH
J Fla Med Assoc; 1983 Sep; 70(9):788-93. PubMed ID: 6355376
[No Abstract] [Full Text] [Related]
11. Pharmacology: Prostin VR.
Hopkins SJ
Nurs Mirror; 1982 Aug; 155(5):48. PubMed ID: 6921719
[No Abstract] [Full Text] [Related]
12. Evaluation of alprostadil (prostaglandin E1) in the management of congenital heart disease in infancy.
Heymann MA; Clyman RI
Pharmacotherapy; 1982; 2(3):148-55. PubMed ID: 6763200
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandins and the management of congenital heart disease.
Taylor WJ; Alpert BS
Am Fam Physician; 1982 Dec; 26(6):127-32. PubMed ID: 6890758
[TBL] [Abstract][Full Text] [Related]
14. [Prostaglandin therapy in newborn infants with a Botalli duct-dependent circulation].
van der Sijp JR; Rohmer J
Tijdschr Kindergeneeskd; 1985 Feb; 53(1):20-5. PubMed ID: 3857721
[TBL] [Abstract][Full Text] [Related]
15. [Prostaglandin treatment of ductus-dependent congenital heart defects].
Olsson B; Björkhem G; Lundström NR
Lakartidningen; 1984 Oct; 81(40):3619-22. PubMed ID: 6541738
[No Abstract] [Full Text] [Related]
16. [Use of prostaglandin E1 in ductus-dependent congenital cardiopathies].
Marcial MB; Maluf M; Atik E; Vargas H; Baucia JA; Verginelli G
Arq Bras Cardiol; 1983 Jun; 40(6):383-6. PubMed ID: 6686760
[No Abstract] [Full Text] [Related]
17. [Bone changes in infants induced by prostaglandin E1 as secondary hypertrophic osteoarthropathy].
Tomiie F; Yamamoto A; Murakami K; Hamaoka K
Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Dec; 42(12):1127-36. PubMed ID: 6892060
[No Abstract] [Full Text] [Related]
18. Histopathology of the ductus arteriosus after prostaglandin E1 administration in ductus dependent cardiac anomalies.
Gittenberger-de Groot AC; Moulaert AJ; Harinck E; Becker AE
Br Heart J; 1978 Mar; 40(3):215-20. PubMed ID: 637973
[TBL] [Abstract][Full Text] [Related]
19. [Skeletal side effects of treatment with prostaglandin E1].
Persigehl M; Hövels-Gürich H; von Bernuth G
Rofo; 1984 Oct; 141(4):427-30. PubMed ID: 6436918
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E1-Induced Periostitis and Reversibility with Discontinuation.
Badheka A; Bangalore Prakash P; Allareddy V
J Pediatr; 2017 Oct; 189():237-237.e1. PubMed ID: 28709628
[No Abstract] [Full Text] [Related]
[Next] [New Search]
